Cargando…

CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial

BACKGROUND: Abnormal health anxiety, also called hypochondriasis, has been successfully treated by cognitive behaviour therapy (CBT) in patients recruited from primary care, but only one pilot trial has been carried out among those attending secondary medical clinics where health anxiety is likely t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyrer, Peter, Cooper, Sylvia, Tyrer, Helen, Salkovskis, Paul, Crawford, Mike, Green, John, Smith, Georgina, Reid, Steven, Dupont, Simon, Murphy, David, Byford, Sarah, Wang, Duolao, Barrett, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141642/
https://www.ncbi.nlm.nih.gov/pubmed/21672205
http://dx.doi.org/10.1186/1471-244X-11-99
_version_ 1782208725117829120
author Tyrer, Peter
Cooper, Sylvia
Tyrer, Helen
Salkovskis, Paul
Crawford, Mike
Green, John
Smith, Georgina
Reid, Steven
Dupont, Simon
Murphy, David
Byford, Sarah
Wang, Duolao
Barrett, Barbara
author_facet Tyrer, Peter
Cooper, Sylvia
Tyrer, Helen
Salkovskis, Paul
Crawford, Mike
Green, John
Smith, Georgina
Reid, Steven
Dupont, Simon
Murphy, David
Byford, Sarah
Wang, Duolao
Barrett, Barbara
author_sort Tyrer, Peter
collection PubMed
description BACKGROUND: Abnormal health anxiety, also called hypochondriasis, has been successfully treated by cognitive behaviour therapy (CBT) in patients recruited from primary care, but only one pilot trial has been carried out among those attending secondary medical clinics where health anxiety is likely to be more common and have a greater impact on services. The CHAMP study extends this work to examine both the clinical and cost effectiveness of CBT in this population. METHOD/DESIGN: The study is a randomized controlled trial with two parallel arms and equal randomization of 466 eligible patients (assuming a 20% drop-out) to an active treatment group of 5-10 sessions of cognitive behaviour therapy and to a control group. The aim at baseline, after completion of all assessments but before randomization, was to give a standard simple explanation of the nature of health anxiety for all participants. Subsequently the control group was to receive whatever care might usually be available in the clinics, which is normally a combination of clinical assessment, appropriate tests and reassurance. Those allocated to the active treatment group were planned to receive between 5 and 10 sessions of an adapted form of cognitive behaviour therapy based on the Salkovskis/Warwick model, in which a set of treatment strategies are chosen aimed at helping patients understand the factors that drive and maintain health anxiety. The therapy was planned to be given by graduate research workers, nurses or other health professionals trained for this intervention whom would also have their competence assessed independently during the course of treatment. The primary outcome is reduction in health anxiety symptoms after one year and the main secondary outcome is the cost of care after two years. DISCUSSION: This represents the first trial of adapted cognitive behaviour therapy in health anxiety that is large enough to test not only the clinical benefits of treatment but also whether the cost of treatment is offset by savings from reduced use of other health services in comparison to the control group. Cognitive behaviour therapy for Health Anxiety in Medical Patients (CHAMP) TRIAL REGISTRATION: Current Controlled Trials ISRCTN14565822
format Online
Article
Text
id pubmed-3141642
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31416422011-07-23 CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial Tyrer, Peter Cooper, Sylvia Tyrer, Helen Salkovskis, Paul Crawford, Mike Green, John Smith, Georgina Reid, Steven Dupont, Simon Murphy, David Byford, Sarah Wang, Duolao Barrett, Barbara BMC Psychiatry Study Protocol BACKGROUND: Abnormal health anxiety, also called hypochondriasis, has been successfully treated by cognitive behaviour therapy (CBT) in patients recruited from primary care, but only one pilot trial has been carried out among those attending secondary medical clinics where health anxiety is likely to be more common and have a greater impact on services. The CHAMP study extends this work to examine both the clinical and cost effectiveness of CBT in this population. METHOD/DESIGN: The study is a randomized controlled trial with two parallel arms and equal randomization of 466 eligible patients (assuming a 20% drop-out) to an active treatment group of 5-10 sessions of cognitive behaviour therapy and to a control group. The aim at baseline, after completion of all assessments but before randomization, was to give a standard simple explanation of the nature of health anxiety for all participants. Subsequently the control group was to receive whatever care might usually be available in the clinics, which is normally a combination of clinical assessment, appropriate tests and reassurance. Those allocated to the active treatment group were planned to receive between 5 and 10 sessions of an adapted form of cognitive behaviour therapy based on the Salkovskis/Warwick model, in which a set of treatment strategies are chosen aimed at helping patients understand the factors that drive and maintain health anxiety. The therapy was planned to be given by graduate research workers, nurses or other health professionals trained for this intervention whom would also have their competence assessed independently during the course of treatment. The primary outcome is reduction in health anxiety symptoms after one year and the main secondary outcome is the cost of care after two years. DISCUSSION: This represents the first trial of adapted cognitive behaviour therapy in health anxiety that is large enough to test not only the clinical benefits of treatment but also whether the cost of treatment is offset by savings from reduced use of other health services in comparison to the control group. Cognitive behaviour therapy for Health Anxiety in Medical Patients (CHAMP) TRIAL REGISTRATION: Current Controlled Trials ISRCTN14565822 BioMed Central 2011-06-14 /pmc/articles/PMC3141642/ /pubmed/21672205 http://dx.doi.org/10.1186/1471-244X-11-99 Text en Copyright ©2011 Tyrer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Tyrer, Peter
Cooper, Sylvia
Tyrer, Helen
Salkovskis, Paul
Crawford, Mike
Green, John
Smith, Georgina
Reid, Steven
Dupont, Simon
Murphy, David
Byford, Sarah
Wang, Duolao
Barrett, Barbara
CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title_full CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title_fullStr CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title_full_unstemmed CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title_short CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
title_sort champ: cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141642/
https://www.ncbi.nlm.nih.gov/pubmed/21672205
http://dx.doi.org/10.1186/1471-244X-11-99
work_keys_str_mv AT tyrerpeter champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT coopersylvia champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT tyrerhelen champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT salkovskispaul champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT crawfordmike champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT greenjohn champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT smithgeorgina champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT reidsteven champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT dupontsimon champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT murphydavid champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT byfordsarah champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT wangduolao champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial
AT barrettbarbara champcognitivebehaviourtherapyforhealthanxietyinmedicalpatientsarandomisedcontrolledtrial